A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is $201.72, with a 24-hour trading volume of $413.33M. The asset's market cap is $312.83B, after moving -1.36% in the last day.
Tokenized AstraZeneca PLC is trading at $105.27, with a tokenized market cap of $14.42M and a 24-hour trading volume of $672.86K. The tokenized asset has moved 3.80% in the past 24 hours.